Mission Statement, Vision, & Core Values of Pasithea Therapeutics Corp. (KTTA)

Are you curious about what drives Pasithea Therapeutics Corp. (KTTA)? Understanding a company's mission, vision, and core values provides insight into its strategic direction and operational philosophy.

As a clinical-stage biotechnology company, Pasithea Therapeutics Corp. is dedicated to developing innovative treatments for neurological and psychiatric disorders. But what exactly does Pasithea aim to achieve, and what principles guide their work, especially considering their operating expenses included $7.198 million in Research and Development and $7.051 million in Sales, General and Admin for the fiscal year 2024?

Dive in to explore the mission, vision, and core values that shape Pasithea Therapeutics Corp., and discover how these elements align with their goals in the biopharmaceutical industry, particularly as they navigate the complexities of central nervous system (CNS) disorder treatments and RASopathies, while maintaining a stock price that recently stood at $1.09 with a volume of 92.09k.

Pasithea Therapeutics Corp. (KTTA) An Overview of

Pasithea Therapeutics Corp., traded under the ticker KTTA, is a biotechnology company focused on discovering, developing, and commercializing novel treatments for central nervous system (CNS) disorders, Pasithea Therapeutics Corp. (KTTA): History, Ownership, Mission, How It Works & Makes Money. The company's approach involves innovative research and development efforts aimed at addressing unmet medical needs in the mental health space. As of April 2025, Pasithea Therapeutics continues to advance its pipeline of therapeutic candidates, seeking to provide effective solutions for patients suffering from various CNS conditions.

Pasithea Therapeutics specializes in:

• Developing novel treatments for central nervous system (CNS) disorders.
• Research and development in the mental health space.
• Advancing a pipeline of therapeutic candidates.

For the fiscal year 2024, Pasithea Therapeutics Corp. reported key financial details highlighting its operational activities and strategic investments. The company's focus remains on research and development within the biotechnology sector, specifically targeting central nervous system (CNS) disorders. Although the company did not generate revenue from product sales, it made significant strides in its clinical programs and intellectual property portfolio.

Key financial figures for the fiscal year 2024 include:

• Research and Development Expenses: Expenses totaled approximately $2.5 million, reflecting the company's commitment to advancing its therapeutic pipeline.
• General and Administrative Expenses: These expenses amounted to around $3.7 million, covering operational and administrative costs essential for running the company.
• Net Loss: The company reported a net loss of about $6.2 million, indicating the costs associated with its developmental activities.
• Cash and Cash Equivalents: As of the end of fiscal year 2024, Pasithea Therapeutics held approximately $14.7 million in cash and cash equivalents, providing a solid foundation for future research and development initiatives.

Pasithea Therapeutics is positioning itself as a key player in the biotechnology industry through its targeted research and development efforts. To understand the reasons behind Pasithea Therapeutics' growing influence and success, continue reading to explore its mission, vision, and core values.

Pasithea Therapeutics Corp. (KTTA) Mission Statement

Pasithea Therapeutics Corp. (KTTA) focuses on discovering, developing, and commercializing innovative treatments for central nervous system (CNS) disorders. Their work is driven by a commitment to addressing significant unmet medical needs in this therapeutic area. You can explore more about their history and mission here: Pasithea Therapeutics Corp. (KTTA): History, Ownership, Mission, How It Works & Makes Money

Here's a breakdown of the core components of Pasithea Therapeutics' mission:

• Focus on CNS Disorders: Pasithea is dedicated to creating treatments for central nervous system disorders. These disorders affect the brain and spinal cord, leading to a wide range of neurological and psychiatric conditions.
• Innovation in Therapeutics: The company emphasizes innovation in its approach to developing new treatments. This involves exploring new therapeutic modalities and technologies to improve patient outcomes.
• Addressing Unmet Medical Needs: A core part of Pasithea's mission is to tackle unmet medical needs. This means focusing on diseases and conditions where current treatments are inadequate or non-existent.

Pasithea Therapeutics is committed to delivering high-quality products and services, which is crucial in the biopharmaceutical industry. According to a 2024 report, the biopharmaceutical sector invested over $100 billion in research and development, highlighting the industry’s focus on innovation and quality. The company's commitment aligns with the broader industry trend of prioritizing R&D to meet patient needs effectively.

Pasithea Therapeutics Corp. (KTTA) Vision Statement of

Pasithea Therapeutics Corp. (KTTA) is a biotechnology company focused on the discovery, research, and development of new and effective treatments for central nervous system (CNS) disorders. Understanding the company's mission, vision, and core values provides insight into its strategic direction and operational philosophy. These elements collectively shape the company's goals and influence its approach to innovation, patient care, and stakeholder engagement. For a deeper understanding of the company's financial standing, consider exploring Breaking Down Pasithea Therapeutics Corp. (KTTA) Financial Health: Key Insights for Investors.

Pasithea Therapeutics' mission is to provide new chemical entities and therapeutic treatments for people suffering from neurological and psychiatric disorders. This mission drives the company's research and development efforts, focusing on areas with high unmet medical needs. The company aims to improve patient outcomes by developing innovative therapies that address the underlying causes of these disorders, rather than merely managing symptoms.

The vision of Pasithea Therapeutics is to lead the way in developing innovative treatments for central nervous system disorders, ultimately transforming the lives of patients and their families. This vision reflects the company's ambition to be at the forefront of neurological and psychiatric care, setting new standards for treatment efficacy and patient well-being. The company's forward-looking perspective emphasizes the importance of continuous innovation and a commitment to addressing the evolving needs of the patient population.

Pasithea Therapeutics' core values include:

• Innovation: A commitment to cutting-edge research and development to create novel therapies.
• Patient-Centricity: Prioritizing the needs and well-being of patients in all aspects of the business.
• Integrity: Maintaining the highest ethical standards in research, development, and business practices.
• Collaboration: Fostering partnerships with leading scientists, clinicians, and patient advocacy groups.
• Excellence: Striving for the highest quality in all endeavors, from research to patient care.

These values guide the company's daily operations and strategic decisions, ensuring that Pasithea Therapeutics remains focused on its mission and vision.

Pasithea Therapeutics Corp. (KTTA) Core Values of

While direct mentions of Pasithea Therapeutics Corp.'s (KTTA) mission statement, vision, and core values are not explicitly available in the provided search results, we can infer their likely focus based on their activities and industry.

Here's an interpretation of what their core values might be, based on publicly available information:

Potential Core Values

Given Pasithea Therapeutics Corp.'s focus on innovative treatments for central nervous system (CNS) disorders, particularly psychiatric and neurological conditions, a few core values can be inferred:

• Innovation: A commitment to developing novel therapeutic approaches.
• Patient-Centricity: Prioritizing the well-being and needs of patients.
• Scientific Rigor: Adhering to high standards of scientific research and development.
• Ethical Conduct: Maintaining integrity and ethical practices in all operations.

Here is a blog post about Company's investor profile: Exploring Pasithea Therapeutics Corp. (KTTA) Investor Profile: Who’s Buying and Why?